-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[
dynamic pharmaceutical industry network Recently, Jiangxi Province medicine procurement services platform release, "Jiangxi centralized drug procurement review rules with the amount of public comment," said the medicine procurement services platform release of Jiangxi Province with centralized drug the amount of purchase comprehensive review rules (draft) for public comment proposals to the community, which marks, another medicine province of centralized procurement volume has not been consistent with the evaluation of drugs will enter the stage of practical operationIn fact, in addition to Jiangxi Province, under normal procurement of background, there are a number of provinces of Shaanxi, Fujian, Hubei, Hunan, Yunnan, Shanxi, Jiangxi, Anhui, Qinghai and other countries with our country in the amount of Union level and even cross-regional alliance procurement have landed and became more Forced lowering the price of medicines to achieve the main forceFor example, April 26, Anhui Province, 18 provincial public sector purchasing consortium with representatives from 26 pharmaceutical manufacturing companies formally signed the success of the negotiations drugs confirmation, the purchase price of an average reduction of 35.16%It is reported that with the amount for the purchase of a cephalosporin is a, two major categories of anti-tumor drugs 35, 29 including cephalosporins and 6 antineoplastic drugsApril 15, Hunan bidding result of purchasing special antibiotic released, a total of 52 varieties of 154 SKUs successfulSuccessful enterprises except for some small and medium enterprises, as well as Pharmaceutical Group, the Shanghai Pharmaceutical, North China Pharmaceutical and other leading companies, the only aspects of multinational pharmaceutical companies Bayer bid154 winning product regulation in a total price of 93 drugs Single / bag / tablet <$ 10, 25 monovalent drugs <$ 1can obviously find with the amount of purchases from more provinces, with provincial coalition to accelerate, even with the amount of municipal centralized procurement, more and more drugs, supplies will enter a price reduction sequenceIndustry experts have said, with the amount of future procurement will enter normalization, and achieved everywhere across the countryIn fact, the main points of the recent 2020 National Health and Social Security Bureau medicine prices and bidding Guidance Center also shows this trendHighlights explicitly mentioned, will vigorously promote the construction of centralized drug procurement agencies and the Standardization, efforts to form a national unity to build an open public procurement market opened Drug Administration Good good stepIn this regard, insiders pointed out that this means that the state and local procurement with the amount of volume purchase simultaneously with the pattern to be formed, combined with a unified drug procurement market, drug information, prices will increasingly the more open and transparentIn the price linkage mechanism, the provinces, the results of the pilot purchasing alliance to cut prices will directly affect the countryWith the success of normalization with the amount of purchase, as well as a unified national information platform for the establishment, plus the price linkage mechanism, the price of generic drugs will speed faster and fasterOverall, in this context, the future of the industry in addition to drug prices will be significantly diminished, the pharmaceutical industry's marketing model, market structure, are facing a very big challenge, but those R & D capability is not strong no unique species or enterprises will be accelerated phase-out.